“While orphan drugs’ share of the $880-billion global pharmaceuticals market remains small—at $50 billion as of the end of 2011, or just 6% of the total—their growth curve has been steep. Thomson Reuters reports that between 2001 and 2010, orphan drugs posted a compound annual growth rate of 25.8%, outstripping the 20.1% CAGR returned by a matched non-orphan control group. With these kinds of eye-popping profits being raked in by orphan drug makers, the investment world has taken notice.”
http://www.caseyresearch.com/cdd/orphans-adding-company-value-in-the-biotech-space
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
(Visited 41 times, 1 visits today)
Related posts:
Our Government Has Weaponized the Internet. Here’s How They Did It
Edward Snowden: The Whistleblower Behind The NSA Surveillance Revelations
Russia election interference debunking brings focus back to Seth Rich murder
Despite Marijuana Reform, the War on Drugs Still Targets People of Color
Chamath Palihapitiya, former Facebook executive speaks about Bitcoin
Vigilante Detroit residents attack suspected rapist after police fail to act
'Patriot Garden' Under Attack In Orlando
Inevitable Terrorist Attack: Will You Be Manipulated?
Chaos and War
Ukraine’s Gold Reserves Secretly Flown Out by the New York Fed?
FAA Releases New Drone List—Is Your Town on the Map?
Russian report on chemical attack indicates similarity with rebel-made weapons
As Chinese Stocks Sink, Bankers Begging Friends For Deposits On WeChat
Homeless, Unemployed, and Surviving on Bitcoins
US plans 'enhanced security' for air travel from 105 countries